BioForward Blog

06Aug 2018

Learn more about this year’s Wisconsin Biohealth Summit here!  BioForward makes it a point to help those involved in the biohealth industry create partnerships and develop networks. So, it’s no surprise that at the 2018 Wisconsin Biohealth Summit coming up on Tuesday October 9th, one of BioForward’s main objectives is to create an environment conducive to making […]

15May 2018

From Local Impact to Global Innovation: GE Healthcare’s Vision of Precision Health Puts Wisconsin at the Forefront of Healthcare Technology   By Kelsey Veldkamp and Kate Rodgers   When it comes to impact, not many Wisconsin companies can boast $22.25 million of total economic production output in the state per day. GE Healthcare continues to […]

09May 2018

A Look in Wisconsin’s Regenerative Medicine Excellence at the 2018 Regenerative Medicine Innovation Awards Monday night, BioForward staff had the chance to attend the 2nd Annual Regenerative Medicine Innovation Awards hosted by UW-Madison’s Stem Cell and Regenerative Medicine Center and sponsored by WiCell, Thermo Fisher Scientific, and Promega. The honoree for the evening was Dr. […]

28Feb 2018

Why the flu vaccine doesn’t always work (and what a Wisconsin company is doing about it) By Kelsey Veldkamp, 2/28/2018   It is no news that the 2017-2018 flu season has been particularly nasty. Nearly every headline written about the current flu season points to high levels of hospitalizations and deaths expected this season—and statistics […]

20Dec 2017

By Kate Rodgers   With company expansions, large acquisitions, and landmark FDA approvals, 2017 has been a year of growth for Wisconsin’s biohealth industry. Particularly, Wisconsin’s biomanufacturing industry has experienced significant growth and is looking to make an even larger impact in 2018. Three Wisconsin biomanufacturing leaders led a discussion on what they see for […]

07Dec 2017

By Liam Selfors While cancers, among many complex multigenic diseases, are often mechanized by precise genetic and environmental underpinnings, they have been traditionally categorized and treated by their location (ie. ‘skin’ cancer or ‘breast’ cancer). Some companies would like you to believe that every drug works for every patient, this is unfortunately not the case. […]